New research from Memorial Sloan Kettering Cancer Center (MSK) discovers a new approach that could prevent chemotherapy-related leukemia; shows how monoclonal antibodies can turn neutrophils into cancer killers; helps develop sensitive CAR T cells that target CD70 antigen to destroy cancer cells; and uses single-cell studies to yield new clues about a rare, aggressive pediatric sarcoma.

Fear that their cancer will progress or worsen is one of the most common concerns among people living with this disease. Several studies indicate that between 20% and 70% of cancer patients experience significant levels of anxiety related to the progression of their health. Identifying and measuring this concern is key to providing appropriate psychological care and improving patients’ quality of life. This has been the aim of a study led by the University of Barcelona (UB), the Universitat Rovira i Virgili (URV) and CEU-San Pablo University, which for the first time has validated in the Spanish population the Spanish version of the Assessment of Survivor Concerns (ASC) questionnaire, a brief tool specifically designed to assess cancer- and health-related concerns.

A randomized crossover pilot study conducted by researchers at the University of Sherbrooke and the Research Centre on Aging in Quebec, Canada, investigated whether moderate-to-high-intensity aerobic exercise performed the day before chemotherapy could influence cancer-related fatigue and active versus sedentary behaviors in the days following treatment. The study, published in Translational Exercise Biomedicine (ISSN: 2942-6812), an official partner journal of International Federation of Sports Medicine (FIMS), provides preliminary evidence that pre-chemotherapy exercise is safe and may offer modest benefits for fatigue management.

The Society of Nuclear Medicine and Molecular Imaging (SNMMI) is pleased to announce that Chun Li, PhD, professor of chemistry in the Department of Cancer Systems Imaging at MD Anderson Cancer Center in Houston, has been selected as the recipient of a $100,000 Drs. Jane & Abass Alavi Mars Shot Research Award from the 2026 Mars Shot Fund. The Alavi Mars Shot Award is focused on advancing imaging research in infection and inflammation, and Li's grant was awarded based on his proposal, "Imaging vascular inflammation and response to therapy in atherosclerotic coronary artery disease."

The Society of Nuclear Medicine and Molecular Imaging (SNMMI) is pleased to announce that Carolyn J. Anderson, PhD--Steve and Karen Ellebracht Professor of Medicinal Chemistry, professor of radiology, and associate director of the Ellis Fischel Cancer Center at the University of Missouri in Columbia--has been selected as the recipient of a $100,000 Drs. Jane & Abass Alavi Mars Shot Research Award from the 2026 Mars Shot Fund. The Alavi Mars Shot Award is focused on advancing imaging research in infection and inflammation, and Anderson s grant was awarded based on her proposal, "Fluorine-18 LLP2A for PET imaging of vaso-occlusive crisis in sickle cell disease."

An NJIT student is lead author of a new study that could help physicians standardize methods for diagnosing and treating squamous cell carcinoma of the colon.